You think use in such other neurological disorders is covered here?
It should be. What’s not covered by the new Botox approval is treatment for idiopathtic OAB, which is a larger market than the indication that was just approved.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.